Analysts Projected EPS of -$0.1 in the current quarter for Spero Therapeutics Inc (NASDAQ:SPRO) Stock
Evercore ISI raised the price target for the Spero Therapeutics Inc (NASDAQ:SPRO) stock from “an In-line” to “an Outperform”. The rating was released on September 23, 2022, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy, with a price target set at $40. The stock was initiated by Berenberg, […]
Spero Therapeutics Inc (SPRO) Stock is looking to regain its victory
Evercore ISI raised the price target for the Spero Therapeutics Inc (NASDAQ:SPRO) stock from “an In-line” to “an Outperform”. The rating was released on September 23, 2022, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy, with a price target set at $40. The stock was initiated by Berenberg, […]
Spero Therapeutics Inc (NASDAQ:SPRO) Stock higher 11.56% in This Year: What’s Happened?
Evercore ISI raised the price target for the Spero Therapeutics Inc (NASDAQ:SPRO) stock from “an In-line” to “an Outperform”. The rating was released on September 23, 2022, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy, with a price target set at $40. The stock was initiated by Berenberg, […]
upgraded: Evercore ISI Recommends Spero Therapeutics Inc (NASDAQ:SPRO) Stock to “an Outperform”
Evercore ISI raised the price target for the Spero Therapeutics Inc (NASDAQ:SPRO) stock from “an In-line” to “an Outperform”. The rating was released on September 23, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings […]